On Friday, the Food and Drug Administration (FDA) revealed its approval of Pfizer’s treatment for a rare genetic bleeding disorder, marking the company’s debut gene therapy to receive clearance in the U.S. Marketed under the name Beqvez, the drug has been given the green light by the agency for adults ...
Read More »Numerous CVS Drug Plans Offer Over-the-Counter Birth Control Pills at Zero Cost
USA – On Thursday, CVS Health announced that its drug plans will now cover the first over-the-counter birth control pill in the U.S. at zero cost for numerous health plan sponsors. This decision has the potential to enable more individuals to prevent unintended pregnancies without needing a prescription. CVS Caremark, ...
Read More »FDA Greenlights Madrigal Pharmaceuticals’ Drug as First-Ever Treatment for Widespread NASH Liver Disease
On Thursday, the Food and Drug Administration granted approval for the inaugural treatment targeting a prevalent and potentially fatal liver condition impacting millions globally. This landmark decision signifies a significant breakthrough for Madrigal Pharmaceuticals, distinguishing it from numerous larger competitors who have struggled or are still striving to penetrate this ...
Read More »Pfizer Ceases Production of Dual-Dose Weight Loss Medication Following Elevated Incidence of Adverse Effects
On Friday, Pfizer announced the discontinuation of the development of the twice-daily variant of its experimental weight loss pill. This decision follows a mid-stage clinical study where obese patients experienced substantial weight loss while facing challenges in tolerating the drug. The pharmaceutical company noted elevated rates of adverse side effects, ...
Read More »Reconsidering Mask Mandates Amid Rising Covid Cases and Variant Concerns in the U.S.
With the recent surge in Covid cases and hospital admissions across the United States, coupled with the appearance of novel virus variants, there is growing uncertainty regarding the need for a resurgence in mask mandates. It is becoming increasingly evident that individuals who are infected with Covid-19 should unequivocally wear ...
Read More »FDA Grants Approval to Pfizer’s Maternal RSV Vaccine for Infants
On Monday, the Food and Drug Administration (FDA) gave its nod to a vaccine developed by Pfizer, designed to safeguard infants against respiratory syncytial virus (RSV), which stands as the primary cause of hospitalizations among infants in the United States. This move follows the prior approval and availability of Pfizer’s ...
Read More »Researchers Identify ‘Microplastics’ in Human Heart for the First Time
In a significant breakthrough, Chinese scientists from Beijing Anzhen Hospital uncovered a groundbreaking revelation during their examination of heart tissue from 15 patients who had undergone cardiovascular surgery. The proliferation of plastics has unleashed serious repercussions on our planet, giving rise to a multitude of environmental challenges. The insidious spread ...
Read More »World Lung Cancer Day 2023: Commemoration, Historical Background, Importance
Lung cancer is among the most deadly forms of cancer, initiating from abnormal cell growth in the vital respiratory organ. According to the National Cancer Institute, lung and bronchus cancer account for the highest number of cancer-related fatalities, with an estimated 127,070 individuals projected to lose their lives to this ...
Read More »Microsoft’s OpenAI-driven App to Boost Efficiency for Doctors at Epic Systems
In an announcement on Tuesday, Nuance Communications, Microsoft’s speech recognition subsidiary, revealed its advanced clinical notes application driven by artificial intelligence (AI) is set to make its way to Epic Systems. The primary objective of this integration is to alleviate the administrative burdens faced by physicians, enabling them to focus ...
Read More »FDA Approves Jardiance and Synjardy for Enhancing Blood Sugar Control in Pediatric Type 2 Diabetes Patients
The U.S. Food and Drug Administration granted approval to Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as supplementary treatments to diet and exercise. These medications aim to enhance blood sugar control in children aged 10 years and above who are diagnosed with type 2 diabetes. This recent approval signifies ...
Read More »